[{"Assets_0_Q2_USD":4387100000.0,"CIK":"1596783","CommonStockSharesConverted_0_Q2_shares":133318039.0,"CommonStockSharesOutstanding_0_Q2_shares":133318039.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":-0.16,"EarningsPerShareBasic_2_Q2_USD":-0.14,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"EarningsPerShareDiluted_2_Q2_USD":-0.14,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":176000000.0,"NetIncomeLossConverted_1_Q2_USD":-21900000.0,"NetIncomeLossConverted_2_Q2_USD":-18100000.0,"OfficialName":"Catalent Inc. Common Stock","RevenuesConverted_1_Q2_USD":40400000.0,"RevenuesConverted_2_Q2_USD":1150200000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":1005500000.0,"StockholdersEquity_0_Q2_USD":1005500000.0,"Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":132983262.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":129327188.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":132983262.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":129327188.0,"filed":"20180205","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2018.0","name":"CATALENT, INC.","period":"20171231","qtrs":"0","uom":"USD"}]